Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-3583
Acta Pharmacol Sin. May 1, 2004; 25 (5): 554-60.

Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.

Yang BF , Xu DH , Xu CQ , Li Z , Du ZM , Wang HZ , Dong DL .


Abstract
To determine the mechanisms of interactions between different drugs and HERG channels.Various antiarrhythmic (dofetilide, quinidine, azimilide, RP58866) and non-antiarrhythmic (terfenadine, nicotine) agents were used on HERG channels expressed in Xenopus oocyte. Whole-cell voltage-clamp techniques were used.All drugs produced concentration-dependent block of HERG current. The inhibition was markedly facilitated with voltage protocols favoring channel inactivation (eg, less negative holding potentials). Maneuvers that weakened channel inactivation (eg, elevation of external K+), relieved HERG blockade by all drugs. Moreover, the inhibitory potency was reduced by at least 20-300 fold with varying compounds when rapid C-type inactivation was removed by a mutation located between the transmembrane domains 5 and 6 (S631A).The inactivation gating of HERG channels determines the blocking potency of drugs. This mechanism might be common to drugs of various classes.

PubMed ID: 15132818
Article link:

Genes referenced: kcnh2
Antibodies referenced:
Morpholinos referenced:

My Xenbase: [ Log-in / Register ]
version: [3.3]


Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556